Japan · Biopharma startup
Japan · Shaperon
Shaperon is a clinical-stage biotech company that develops inflammasome inhibitors.
Funding reportedLast round: Series C
What company datasets say Shaperon raised
Funding, as reported
Reported in all26Bin the source's currency
Rounds1
Last roundSeries C
Last round dateOct 2020
Investors listed9
On a portfolio page
Investors who name them
Each firm lists Shaperon on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biopharma in Japan
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Shaperon in front of investors. Or tell us what we have wrong.